| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8458066 | Pathology - Research and Practice | 2018 | 5 Pages |
Abstract
The present study provides evidence that TRIM44 predicts the risk of development and prognosis of EC, highlighting its potential application as a therapeutic target for this malignancy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Panpan Li, Hexuan Yin, Fanling Meng, Shuang Liu, Haixia Liu, Rong Ma,